RIL
VNDA icon

Rothschild Investment LLC’s Vanda Pharmaceuticals VNDA Stock Holding History

Rothschild Investment LLC’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36K Buy
1,530
+799
+109% +$5.22K ﹤0.01% 1920
2026
Q1 		$5.05K Buy
731
+442
+153% +$3.41K ﹤0.01% 2046
2025
Q4 		$2.55K Buy
289
+94
+48% +$517 ﹤0.01% 2242
2025
Q3 		$973 Sell
195
-55
-22% -$255 ﹤0.01% 2585
2025
Q2 		$1.18K Buy
+250
New +$1.09K ﹤0.01% 2373

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's VNDA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Vanda Pharmaceuticals (VNDA) stake by 109% in Q2 2026, buying an estimated $5.22K and bringing the position to 1,530 shares worth $9.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

Rothschild Investment LLC first reported a position in VNDA in Q2 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Rothschild Investment LLC held 1,530 shares of Vanda Pharmaceuticals worth $9.36K as of Q2 2026.
  • Rothschild Investment LLC bought 799 Vanda Pharmaceuticals shares in Q2 2026, an estimated $5.22K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1920 holding.
  • Rothschild Investment LLC first reported a position in Vanda Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.